Lecia Sequist, MD, MPH

Lecia Sequist, MD, MPH

Episodes

Specialty:

All

Year:

All

EP. 1: EGFR TKIs for Upfront Treatment of NSCLC

February 11th 2016

EP. 2: EGFR Mutations and Targeted Therapy in NSCLC

February 11th 2016

EP. 3: Mechanisms of Resistance to Upfront EGFR-Targeted Therapy

February 11th 2016

EP. 4: Sequencing of Therapies in EGFR-Mutant NSCLC

February 11th 2016

Trending on OncLive

Intismeran Autogene Plus Pembrolizumab Meets RFS and DMFS End Points in Resected Stage IIB-IV Melanoma

ESMO Guidelines Express Update Recommends Daraxonrasib for RAS G12–Mutated Metastatic PDAC

Mo-Rez Advances Into Combination Studies Following Robust Responses in Gynecologic Cancers

mRNA Vaccines May Help Increase Long-Term Disease Control in PDAC

FDA Grants Fast Track Designation to PLN-101095 Plus Pembrolizumab in Solid Tumors